BioXcel Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing buying pressure, which is a positive indicator for future bullish movement.

BioXcel Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 18.87 Sell
20-day SMA: 23.98 Sell
50-day SMA: 28.08 Sell
200-day SMA: 18.1 Buy
8-day EMA: 19.38 Sell
20-day EMA: 22.64 Sell
50-day EMA: 24.84 Sell
200-day EMA: 21.03 Sell

BioXcel Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.08 Sell
Relative Strength Index (14 RSI): 26.92 Sell
Chaikin Money Flow: 503402 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.83 - 30.77) Sell
Bollinger Bands (100): (16.07 - 29.65) Sell

BioXcel Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for BioXcel Therapeutics Stock

Is BioXcel Therapeutics Stock a Buy?

BTAI Technical Analysis vs Fundamental Analysis

BioXcel Therapeutics (BTAI) is a Sell

Is BioXcel Therapeutics a Buy or a Sell?

BioXcel Therapeutics Stock Info

Market Cap:
Price in USD:
Share Volume:

BioXcel Therapeutics 52-Week Range

52-Week High:
52-Week Low:
BioXcel Therapeutics (BTAI) is a Sell

BioXcel Therapeutics Share Price Forecast

Is BioXcel Therapeutics Stock a Buy?

Fundamental Analysis of BioXcel Therapeutics

Is BioXcel Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.17 per share, and an increase next year of $1.92 per share.

Technical Analysis of BioXcel Therapeutics

Should I short BioXcel Therapeutics stock?

* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.